9D1E14D8-F2D6-4C01-B5AF-BA0CC3FE6A1FCANCER: Trials with potential global reach and other challenging trialsIntramuralMC_UU_12023/28C008C651-F5B0-4859-A334-5F574AB6B57CMRCEXPENDITURE_ACTUAL91640000B153602-2CD0-482B-97B6-6A5A419B596BPatients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile?Annals of oncology : official journal of the European Society for Medical Oncologye733ae1770707aa2394b9e9fd43a39fcBlinman PL2018-01-01http://dx.doi.org/10.1093/annonc/mdx71529177440http://ukpmc.ac.uk/abstract/MED/291774400923-7534http://europepmc.org/abstract/MED/29177440292Journal Article/Review5c76bd9b067015.20402430